A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed/Refractory Hematologic Malignancies
Clinical trial NCT06492304 · COMPLETED
Trial details
- NCT number
- NCT06492304
- Sponsor
- CRISPR Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-13
- Primary completion
- 2026-03-11
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.